GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
6WMO | Q9NY97 | Human poly-N-acetyl-lactosamine synthase structure demonstrates a modular assembly of catalytic subsites for GT-A glycosyltransferases | |
4XZ2 | Q01813 | Human platelet phosphofructokinase in an R-state in complex with ADP and F6P, crystal form I | |
7O58 | O15305 | Human phosphomannomutase 2 (PMM2) with mutation T237M in complex with the activator glucose 1,6-bisphosphate | |
7O4G | O15305 | Human phosphomannomutase 2 (PMM2) wild-type soaked with the activator glucose 1,6-bisphosphate | |
7O1B | O15305 | Human phosphomannomutase 2 (PMM2) wild-type co-crystallized with the activator glucose 1,6-bisphosphate | |
7LW1 | P17858 | Human phosphofructokinase-1 liver type bound to activator NA-11 | |
7VWE | Q03181 | Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with a synthetic partial agonist JK122 | |
7VWG | Q03181 | Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with a synthetic alpha/delta dual agonist JKPL38 | |
7VWF | Q03181 | Human peroxisome proliferator-activated receptor (PPAR) delta ligand binding domain in complex with a synthetic agonist TIPP204 | |
3F9M | P35557 | Human pancreatic glucokinase in complex with glucose and activator showing a mobile flap | |
3IDH | P35557 | Human pancreatic glucokinase in complex with glucose | |
4GQQ | P04746 | Human pancreatic alpha-amylase with bound ethyl caffeate | Pancreatic alpha-amylase (E.C.3.2.1.1) |
2QV4 | P04746 | Human pancreatic alpha-amylase complexed with nitrite and acarbose | |
2QMK | P04746 | Human pancreatic alpha-amylase complexed with nitrite | |
3BAW | P04746 | Human pancreatic alpha-amylase complexed with azide | Pancreatic alpha-amylase (E.C.3.2.1.1) |
5ML5 | Q16539 | Human p38alpha MAPK in complex with imidazolyl pyridine inhibitor 11b | |
4L8M | Q16539 | Human p38 MAP kinase in complex with a Dibenzoxepinone | |
3IW5 | Q16539 | Human p38 MAP Kinase in Complex with an Indole Derivative | |
3IW7 | Q16539 | Human p38 MAP Kinase in Complex with an Imidazo-pyridine | |
3UVQ | Q16539 | Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative | |
3IW6 | Q16539 | Human p38 MAP Kinase in Complex with a Benzylpiperazin-Pyrrol | |
3UVP | Q16539 | Human p38 MAP Kinase in Complex with a Benzamide Substituted Benzosuberone | |
3QUE | Q16539 | Human p38 MAP Kinase in Complex with Skepinone-L | |
3HUB | Q16539 | Human p38 MAP Kinase in Complex with Scios-469 | |
3LFC | Q16539 | Human p38 MAP Kinase in Complex with RL99 | |
3LFB | Q16539 | Human p38 MAP Kinase in Complex with RL98 | |
3HV4 | Q16539 | Human p38 MAP Kinase in Complex with RL51 | |
3HV3 | Q16539 | Human p38 MAP Kinase in Complex with RL49 | |
3HUC | Q16539 | Human p38 MAP Kinase in Complex with RL40 | |
3HV6 | Q16539 | Human p38 MAP Kinase in Complex with RL39 | |
3HV7 | Q16539 | Human p38 MAP Kinase in Complex with RL38 | |
3HV5 | Q16539 | Human p38 MAP Kinase in Complex with RL24 | |
3PG3 | Q16539 | Human p38 MAP Kinase in Complex with RL182 | |
3LFF | Q16539 | Human p38 MAP Kinase in Complex with RL166 | |
3LFE | Q16539 | Human p38 MAP Kinase in Complex with RL116 | |
3LFD | Q16539 | Human p38 MAP Kinase in Complex with RL113 | |
3UVR | Q16539 | Human p38 MAP Kinase in Complex with KM064 | |
5TCO | Q16539 | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | |
3LFA | Q16539 | Human p38 MAP Kinase in Complex with Dasatinib | |
3L8S | Q16539 | Human p38 MAP Kinase in Complex with CP-547632 | |
3QUD | Q16539 | Human p38 MAP Kinase in Complex with 2-amino-phenylamino-benzophenone | |
8IYG | Q9UKL4 | Human neuronal gap junction channel connexin 36 | |
5ET8 | O00757 | Human muscle fructose-1,6-bisphosphatase in active R-state in complex with fructose-6-phosphate | |
5K56 | O00757 | Human muscle fructose-1,6-bisphosphatase in active R-state in complex with fructose-1,6-bisphosphate | |
3IFC | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in complex with AMP and alpha fructose-6-phosphate | |
5K55 | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in active R-state in complex with fructose-6-phosphate | |
5L0A | O00757 | Human muscle fructose-1,6-bisphosphatase E69Q mutant in active R-state in complex with fructose-1,6-bisphosphate | |
5NST | 5NST | Human monoclonal antibody with a LAIR1 insertion | |
5C5C | Q14831 | Human metabotropic glutamate receptor 7, extracellular ligand binding domain | |
6UOA | Q9UBS5 | Human metabotropic GABA(B) receptor in its intermediate state 1 | Gamma-aminobutyric acid type B receptor subunit 1, Gamma-aminobutyric acid type B receptor subunit 2 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024